OFFICIAL PUBLICATION OF

by its subsidiary APPco

Confusion with Wegovy prescriptions

Guest Author 16/09/2024

PDL offers advice for pharmacists regarding Wegovy (semaglutide) following a number of incident reports Pharmacists are likely aware that Wegovy (semaglutide) is now available in Australia. The PDL Professional Officers have received several incident reports involving patients being supplied with the incorrect strength of the product. Wegovy is available as a FlexTouch Pen containing four

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Confusion with Wegovy prescriptions

Previous Do complaint reports go too far?

Next Limited PBS access, shortages may impact add-on therapy

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Do complaint reports go too far?

Next Limited PBS access, shortages may impact add-on therapy

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.